Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia

Brain

Volumn 135, Issue 5, 2012, Pages 1554-1565

  Gefen, Tamar ^a   Gasho, Katherine ^a   Rademaker, Alfred ^a   Lalehzari, Mona ^a   Weintraub, Sandra ^a   Rogalski, Emily ^a   Wieneke, Christina ^a   Bigio, Eileen ^a   Geula, Changiz ^a   Mesulam, M Marsel ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

AD pathology; hemispheric differences; neurodegenerative disorders; primary progressive aphasia; stereology

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; AMNESIA; AMYLOID PLAQUE; ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; ENTORHINAL CORTEX; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NEOCORTEX; NEUROFIBRILLARY TANGLE; PERFUSION; PHENOTYPE; PRIMARY PROGRESSIVE APHASIA; PRIORITY JOURNAL; RIGHT HEMISPHERE;

EID: 84860633148     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws076     Document Type: Article

References (51)

1. Arriagada PV, Growdon JH, Hedley-Whyte T, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992; 42 (Pt 1): 631-9.
2. Benson DF, Davis RJ, Snyder BD. Posterior cortical atrophy. Arch Neurol 1988; 45: 789-93.
3. Bierer LM, Hof PR, Purohit DP, Carlin L, Schmeidler J, Davis KL, et al. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch Neurol 1995; 52: 81-8.
4. Bobinski M, Wegiel J, Wisniewski HM, Tarnawski M. Neurofibrillary pathology-correlation with hippocampal formation atrophy in Alzheimer disease. Neurobiol Aging 1996; 17: 909-19.
5. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-59.
6. Braak H, Braak E. Evolution of the neuropathology of Alzheimer's disease. Acta Neurol Scand Suppl 1996; 165: 3-12.
7. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-3.
8. Engel PA, Fleming PD. Primary progressive aphasia, left anterior atrophy, and neurofibrillary hippocampal pathology: observations in an unusual case. Neuropsychiatry Neuropsychol Behav Neurol 1997; 10: 213-8.
9. Galton CJ, Patterson K, Xuereb JH, Hodges JR. Atypical and typical presentations of Alzheimer's disease: a clinical neuropsychological, neuroimaging and pathological study of 13 cases. Brain 2000; 123: 484-98.
10. Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002; 15: 870-8.
11. Gliebus G, Bigio EH, Gasho K, Mishra M, Caplan D, Mesulam MM, et al. Asymmetric TDP-43 distribution in primary progressive aphasia with progranulin mutation. Neurology 2010; 74: 1607-10.
12. Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology 2011; 76: 1006-14.
13. Green J, Morris JC, Sandson J, McKeel DW Jr, Miller JW. Progressive aphasia: a precursor of global dementia? Neurology 1990; 40 (Pt 1): 423-9.
14. Greene JDW, Patterson K, Xuereb J, Hodges JR. Alzheimer disease and nonfluent progressive aphasia. Arch Neurol 1996; 53: 1072-8.
15. Guillozet AL, Weintraub S, Mash DC, Mesulam MM. Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol 2003; 60: 729-36.
16. Hof PR, Vogt BA, Bouras C, Morrison JH. Atypical form of Alzheimer's disease with prominent posterior cortical atrophy: a review of lesion distribution and circuit disconnection in cortical visual pathways. Vision Res 1997; 37: 3609-25.
17. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984; 225: 1168-70.
18. Jagust WJ, Davies P, Tiller-Borcich JK, Reed BR. Focal Alzheimer's disease. Neurology 1990; 40: 14-9.
19. Jagust WJ, Landau SM, Shaw LM, Trojanowski JQ, Koeppe RA, Reiman EM, et al. Relationships between biomarkers in aging and dementia. Neurology 2009; 73: 1193-9.
20. Johnson JK, Head E, Kim R, Starr A, Cotman CW. Clinical and pathological evidence for a frontal variant of Alzheimer disease. Arch Neurol 1999; 56: 1233-9.
21. Kempler D, Metter EJ, Riege WH, Jackson CA. Slowly progressive aphasia: three cases with language, memory, CT and PET data. J Neurol Neurosurg Psych 1990; 53: 987-93.
22. Knibb JA, Xuereb JH, Patterson K, Hodges JR. Clinical and pathological characterization of progressive aphasia. Ann Neurol 2006; 59: 156-65.
23. Li F, Iseki E, Kato M, Adachi Y, Akagi M, Kosaka K. An autopsy case of Alzheimer's disease presenting with primary progressive aphasia: a clinicopathological and immunohistochemical study. Neuropathology 2000; 20: 239-45.
24. Li X, Rowland LP, Mitsumoto H, Przedborski S, Bird TD, Schellenberg GD, et al. Prion protein codon 129 genotype prevalence is altered in primary progressive aphasia. Ann Neurol 2005; 58: 858-64.
25. Lind J, Larsson A, Persson J, Ingvar M, Nilsson LG, Backman L, et al. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory. Neurosci Lett 2006; 20: 23-7.
26. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-44.
27. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia. Arch Neurol 2001; 58: 1803-9.
28. Mesulam MM. Slowly progressive aphasia without generalized dementia. Ann Neurol 1982; 11: 592-8.
29. Mesulam MM. Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles. Neuron 1999; 24: 521-9.
30. Mesulam MM. Primary progressive aphasia. Ann Neurol 2001; 49: 425-32.
31. Mesulam MM. Primary progressive aphasia: a language-based dementia. N Engl J Med 2003; 349: 1535-42.
32. Mesulam M, Shaw P, Mash D, Weintraub S. Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann Neurol 2004; 55: 815-28.
33. Mesulam M, Weintraub S, Parrish T, Gitelman D. Primary progressive aphasia: reversed asymmetry of atrophy and right hemisphere language dominance. Neurology 2005; 64: 556-7.
34. Mesulam M, Wicklund A, Johnson N, Rogalski E, Leger GC, Rademaker A, et al. Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol 2008; 63: 709-19.
35. Mesulam M, Wieneke C, Rogalski E, Cobia D, Thompson C, Weintraub S. Quantitative template for subtyping primary progressive aphasia. Arch Neurol 2009; 66: 1545-51.
36. Mesulam MM, Weintraub S. Spectrum of primary progressive aphasia. In: Rossor MN, editor. Unusual Dementias Balliere's clinical neurology. London: Baillière Tindall; 1992. p. 583-609.
37. Morris JC, Heyman A, Mohs RC, Hughes JP. The consortium to establish a registry for Alzheimer's disease (CERAD): I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989; 39: 1159-65.
38. Munoz DG, Woulfe J, Kertesz A. Argyrophilic thorny astrocyte clusters in association with Alzheimer's disease pathology in possible primary progressive aphasia. Acta Neuropathol 2007; 114: 347-57.
39. Nelissen N, Vandenbulcke M, Fannes K, Verbruggen A, Peeters R, Dupont P, et al. A beta amyloid deposition in the language system and how the brain responds. Brain 2007; 130: 2055-69.
40. Ng SY, Villemagne VL, Masters CL, Rowe CC. Evaluating atypical dementia syndromes using positron emission tomography with carbon 11-labeled Pittsburgh Compound B. Arch Neurol 2007; 64: 1140-4.
41. Rabinovici GD, Jagust WJ, Furst AJ, Ogar JM, Racine CA, Mormino EC, et al. A beta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol 2008; 64: 388-401.
42. Rogalski E, Cobia D, Harrison TM, Wieneke C, Thompson CK, Weintraub S, et al. Anatomy of language impairments in primary progressive aphasia. J Neurosci 2011; 31: 3344-50.
43. Rogalski E, Johnson N, Weintraub S, Mesulam M. Increased frequency of learning disability in patients with primary progressive aphasia and their first-degree relatives. Arch Neurol 2008; 65: 244-8.
44. Rogalski E, Mesulam M. An update on primary progressive aphasia. Curr Neurol Neurosci Rep 2007; 7: 388-92.
45. Rogalski EJ, Rademaker A, Harrison TM, Helenowski IH, Johnson N, Bigio E, et al. ApoE E4 is a susceptibility factor in amnestic but not aphasic dementias. Alzheimer Dis Associat Dis 2011; 25: 159-63.
46. Rohrer JD, Rossor MN, Warren JD. Alzheimer's pathology in primary progressive aphasia. Neurobiol Aging 2010; 33: 744-52.
47. Shewan CM, Kertesz A. Reliability and validity characteristics of the western aphasia battery (WAB). J Speech Hear Disord 1980; 45: 308-24.
48. Sobrido MJ, Abu-Khalil A, Weintraub S, Johnson N, Quinn B, Cummings JL, et al. Possible association of the tau H1/H1 genotype with primary progressive aphasia. Neurology 2003; 60: 86-4.
49. Tang-Wai D, Mapstone M. What are we seeing? Is posterior cortical atrophy just Alzheimer disease? Neurology 2006; 66: 300-1.
50. Wechsler D. A standardized memory scale for clinical use. J Psychol 1945; 19: 87-95.
51. Weintraub S, Mesulam M-M. Four neuropsychological profiles in dementia. In: Boller F, Grafman J, editors. Handbook of neuropsychology. Vol. 8. Amsterdam: Elsevier; 1993. p. 253-82.